Please assess the completion status of the following clinical trial:

Trial Title: CUTE (Chronic Urticaria Treatment Evaluation)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- At visit 1: Clinical history of Chronic Idiopathic Urticaria for a period of at least 6 weeks during the last 3 months without an identifiable cause~- At visit 2 (after a baseline period of at least 3 days): patient with adequate signs of CIU, both in terms of symptoms and severity.~Exclusion Criteria:~- Any condition that would interfere with the evaluation of the therapeutic response.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Levocetirizine (Type: EXPERIMENTAL): Levocetirizine, once daily, 4 week duration
- Desloratadine (Type: ACTIVE_COMPARATOR): Desloratadine, once daily, 4 week duration

Based on this trial design, predict the completion outcome and termination type (if applicable).